These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6498064)

  • 1. Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
    Alanko A; Heinonen E; Scheinin TM; Tolppanen EM; Vihko R
    Br J Cancer; 1984 Nov; 50(5):667-72. PubMed ID: 6498064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
    Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
    Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
    Howat JM; Harris M; Swindell R; Barnes DM
    Br J Cancer; 1985 Feb; 51(2):263-70. PubMed ID: 3966982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors as prognostic factors in early breast cancer.
    Saez S; Cheix F; Mayer M
    Recent Results Cancer Res; 1984; 91():192-8. PubMed ID: 6729216
    [No Abstract]   [Full Text] [Related]  

  • 5. Progesterone and oestrogen receptors in human breast cancer.
    Holdaway IM; Mountjoy KG
    Aust N Z J Med; 1978 Dec; 8(6):630-8. PubMed ID: 285684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
    Alanko A; Heinonen E; Scheinin T; Tolppanen EM; Vihko R
    Cancer; 1985 Oct; 56(7):1696-700. PubMed ID: 4027900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
    Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP
    Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor protein in breast cancer as a predictor of recurrence.
    Kinne DW; Ashikari R; Butler A; Menendez-Botet C; Rosen PP; Schwartz M
    Cancer; 1981 May; 47(10):2364-7. PubMed ID: 7272892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA; Davidson AL; Kopel S; Schreibman B; Gelbfish JS; Degenshein GA; Herz BL; Cunningham JN
    Ann Surg; 1988 Jan; 207(1):75-9. PubMed ID: 3337566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptors as a prognostic factor in Stage II breast cancer.
    Clark GM; McGuire WL; Hubay CA; Pearson OH; Marshall JS
    N Engl J Med; 1983 Dec; 309(22):1343-7. PubMed ID: 6633596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive power of progesterone receptor status in early breast carcinoma.
    Sutton R; Campbell M; Cooke T; Nicholson R; Griffiths K; Taylor I
    Br J Surg; 1987 Mar; 74(3):223-6. PubMed ID: 3567519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
    Thorpe SM; Rose C
    Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.
    Vassilaros S; Adamopoulos DA; Papadiamantis J; Dessypris A; Kapolla N
    Anticancer Res; 1981; 1(4):195-7. PubMed ID: 7345966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
    Cherubini M; Baxa P; Guarino G
    Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.